Scientists at the Buck Institute for Research on Aging have shown that an orally administered small molecule, ...
Immunoglobulin A (IgA) nephropathy is an autoimmune disease characterized by the deposition of circulating IgA-containing ...
A Medical College of Georgia researcher is tracing the pathway that leads people with hypertension to kidney damage and possible kidney destruction. He's found a key vasodilator that is degraded in ...
Diabetes is a leading cause of kidney disease, a serious, often fatal complication that is difficult to diagnose in early, potentially treatable stages. Now, a research team at the Icahn School of ...
TMAO (trimethylamine N-oxide) is a metabolite produced by gut bacteria and has emerged as a metabolite of interest due to its association with cardiovascular disease. Now, new findings from the ...
NASHVILLE, Tenn. -- Building on the existing immune checkpoint inhibitor (ICI) platform, new treatment strategies for renal cell carcinoma (RCC) seek to adapt the cancer's immunity cycle to inform ...
This is an ASCO Meeting Abstract from the 2022 ASCO Genitourinary Cancers Symposium. This abstract does not include a full text component.
—Using observational, real-world data from a large Veterans Administration database, these investigators compared cardiorenal endpoints in patients with T2DM taking SGLT2s, GLP-1s, DPP-4s, or ...
FDA confirmed that eGFR slope is an acceptable surrogate endpoint for accelerated approval of rilparencel in patients with CKD and type 2 diabetes FDA also confirmed that the ongoing Phase 3 PROACT 1 ...
Everyday Health on MSN
Treatment options for metastatic and recurrent renal cell carcinoma
Immunotherapy and targeted therapy are often the first lines of treatment for advanced kidney cancer, with surgery and radiation also possible.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results